h i g h l i g h t s
Slow-delta oscillations that alternate with gamma oscillations (gamma burst) occur with ketamine at general anesthesia levels. Gamma, theta and decreased alpha/beta oscillations are not unique to ketamine at general anesthesia levels. The gamma burst pattern may result from circuit disruptions in cortical and subcortical sites.
a b s t r a c t
Objectives: Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist commonly administered as a general anesthetic. However, neural circuit mechanisms to explain ketamine anesthesia-induced unconsciousness in humans are yet to be clearly defined. Disruption of frontal-parietal network connectivity has been proposed as a mechanism to explain this brain state. However, this mechanism was recently demonstrated at subanesthetic doses of ketamine in awake-patients. Therefore, we investigated whether there is an electroencephalogram (EEG) signature specific for ketamine anesthesia-induced unconsciousness. Methods: We retrospectively studied the EEG in 12 patients who received ketamine for the induction of general anesthesia. We analyzed the EEG dynamics using power spectral and coherence methods. Results: Following the administration of a bolus dose of ketamine to induce unconsciousness, we observed a ''gamma burst" EEG pattern that consisted of alternating slow-delta (0.1-4 Hz) and gamma ($27-40 Hz) oscillations. This pattern was also associated with increased theta oscillations ($4-8 Hz) and decreased alpha/beta oscillations ($10-24 Hz). Conclusions: Ketamine anesthesia-induced unconsciousness is associated with a gamma burst EEG pattern. Significance: The EEG signature of ketamine anesthesia-induced unconsciousness may offer new insights into NMDA circuit mechanisms for unconsciousness. Ó 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist that is used as a dissociative anesthetic (Domino et al., 1965; Corssen and Domino, 1966 ), a research model for schizophrenia (Insel, 2010) , and a fast acting treatment for major depressive disorder (Zarate et al., 2006) . At low doses, ketamine produces a dissociative state characterized by hallucinations, altered sensory perception and analgesia, while at higher doses it induces a state of unconsciousness appropriate for general anesthesia. For instance, an intravenous induction dose of ketamine (1-2 mg/kg) causes a rapid loss of consciousness that typically lasts for 
